Top Tweets for #BioTechBoom
🚀 IBRX hype level: MAX! NCCN just added #ANKTIVA for papillary NMIBC—insurance floodgates OPEN! Stock at $8.21 close, after-hours $8.34. Short-term pred: $10+ surge tomorrow. Chemo-free wins! 🔥
#IBRX #NCCNWin #BiotechBoom
700% revenue explosion in ONE year?! 😱 ImmunityBio's ANKTIVA is crushing it—now approved in Europe too! 33 countries, BCG combo, outpatient magic. $IBRX holders: you still holding? Drop a 🔥 if yes! #ImmunityBio #BiotechBoom
💄 Small Cap Sunday Rare Disease Rebel: @SavaraPharma files BLA for lung treatment—empowering U.S. healthcare innovation & red wave returns! Undervalued play. $SVRA up 2.9% this week! 🌟🇺🇸 #BiotechBoom #StockQueen #BoldStocks #MAGA
$NKTR Still ripping +50%+ on atopic dermatitis trial positivity – small-cap biotech lottery hitting! Message volume insane, sentiment max bullish 🔥 #smallcap #biotechboom
1/8: 🚀 $IBRX is on FIRE! Just smashed a new 52-week high at $5.39, up over 100% in the past week. Anktiva sales exploded—$113M prelim 2025 revenue, 700% YoY growth! FDA-approved for bladder cancer + fresh Saudi approval. Execution is real. #IBRX #BiotechBoom #ShortSqueeze #Stocks
🚀Stock Alert: $Biotech Boom Today! 🚀
$WVE surges +147% on obesity drug trial wins—mOS 8.9 months! GPCR jumps +102% with Phase 2 data crushing benchmarks. $CETX up +129% on earnings squeeze. AI king $NVDA +2% pre-market. What's your play? #Stocks #BiotechBoom
Eyes on 2026 for $ARWR: Top-line data from Shasta Phase 3 (SHTG expansion), obesity trial results, & ARO-MAPT CSF tau readout.
Multiple label expansions + new launches could 10x value. Get in early!
#BiotechBoom
South Korea’s KOSDAQ hosts more biotech firms than any other Asian exchange—making it one of the region’s biggest innovation hubs. 🚀🔬
#GlobalMarkets #BiotechBoom #KOSDAQ #MarketInsights #InvestingFacts
🚀 PharmaMar ajusta motores, la luna cada vez más cerca 🌕🔭. Que nadie se baje ahora… ¡el viaje continúa y el tablero aún no ha mostrado su mate! ♟️🔥#PharmaMar #ToTheMoon #BioTechBoom
#Marketsbets
Verdict: 2020 pumped on hype. 2025 BNGO at similar lows? Built on PROOF—adoption escaping velocity.
10x-50x incoming when OGM hits standard-of-care (it’s happening). Load under $2 while it’s quiet—real moonshot loading. 💎🙌
#BNGO #WallStreetBets #BiotechBoom
Cyber Squeeze Setup: $CYCU tanks to $0.15 bid on Nasdaq delisting notice, but Oct 20 appeal + 30:1 reverse split (Oct 27) eyes compliance rebound! Oversold RSI ~25 screams short-cover pop—215% to $0.50 target. Buy the panic! 🚀 #CYCU #BiotechBoom
$CYCU's oversold cyber powerhouse eyes $0.50 target (99% upside) from battered $0.25, with rock-solid supports at $0.25/$0.20/$0.18. This resilient IT defender's poised for rebound—grab the dip on gov't contract gold!
🚨 $ANRO EXPLODING TO $12 ON $50M BIOTECH FUNDING BOMB! 💥🧬
From $6.7 to DOUBLE in a DAY—major players backing Phase 3 trials for game-changing drug. Whales piling in, volume surging! Next $GSIT moonshot? Load NOW before liftoff! 🔥📈 #ANRO #BiotechBoom
I’m up 200% 😇
📈 $BNGO consumables crushing it—high-margin, double-digit growth via utilization focus! Accelerating into 2026, biggest revenue driver! 🔥🧪 #BNGO #BiotechBoom
Biotech Frenzy: $GTBP rockets 44% to $1.08 on GTB-3650 Phase 1 wins—cohort 4 dosing by year-end!
Sector explodes w/ $8B deals amid economic rebound—300%+ upside! Buy now! #GTBP #BiotechBoom
Biotech Rebound: $MLTX surges 27% from Oct lows post-Phase 3 miss—analysts hold Strong Buy, $23 PT (160%+ upside)!
Sonelokimab pipeline rocks for HS/PsA—buy the dip! #MLTX #BiotechBoom
MedTech Surge: $BFLY blasts 19% to $2.33 on record Q2 revenue $23.4M (+9% YoY) & 64% margins!
Strong Buy, $4.31 PT (85% upside).
Compass AI Q3 launch—load up! #BFLY #BiotechBoom
Biotech Surge: $INDP rockets 23% to $3.68 on clinical trial optimism & fresh capital raise—major milestone hit in INDP-D101 monotherapy, now combo dosing!
Estimated price target of $25 (upside potential over 600%).
Strong Buy - Add to holdings! #INDP #BioTechBoom
Biotech Surge: $LRMR rockets 28% to $4.15 on stellar nomlabofusp data for Friedreich's ataxia—long-term study wows!
Zacks #1 Strong Buy, $7 PT (70%+ upside). Earnings Oct 29—load up!
#LRMR #BiotechBoom
$QURE Breaking: uniQure's AMT-130 just crushed Huntington's trials—75% slower disease progression at 36 months!
First therapy to truly fight back. Stock up 200%+ today.
Gene therapy revolution is here!
#QURE #BiotechBoom #HuntingtonsResearch
$MTSR is surging thanks to the booming GLP-1 obesity drug market!
With demand exploding for weight loss treatments, Metsera's innovative peptides position it as a top contender against giants like Novo Nordisk.
Analysts see 68% upside—time to watch!
#MTSR #BiotechBoom
Last Seen Hashtags on Sotwe
BooneSucks
Seen from United States
momson or #exny or #nolimit() +filter:native_video
Seen from Netherlands
신던양말
Seen from Korea
BreedBlack
Seen from Germany
bbc
Seen from United States
إيران
Seen from Saudi Arabia
nazillitravesti
Seen from Turkey
VOTEBLUE2026MidTerms
Seen from Japan
priyankamohan
Seen from Netherlands
R18
Seen from Poland
Trends for you
Most Popular Users
Elon Musk 
@elonmusk
240.8M followers
Barack Obama
@barackobama
119.2M followers
Donald J. Trump
@realdonaldtrump
111.7M followers
Cristiano Ronaldo
@cristiano
111.3M followers
Narendra Modi
@narendramodi
107M followers
Rihanna
@rihanna
97.8M followers
NASA
@nasa
92.2M followers
Justin Bieber
@justinbieber
91M followers
KATY PERRY
@katyperry
88M followers
Taylor Swift
@taylorswift13
81.9M followers
Lady Gaga
@ladygaga
73.4M followers
Virat Kohli
@imvkohli
70.5M followers
Kim Kardashian
@kimkardashian
70M followers
YouTube
@youtube
68.7M followers
Bill Gates
@billgates
64.1M followers
Neymar Jr
@neymarjr
63.3M followers
The Ellen Show
@theellenshow
62.4M followers
CNN
@cnn
61.9M followers
Selena Gomez
@selenagomez
61.1M followers
X
@x
60.8M followers